We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+10.8%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$433B
AUM Growth
+$39.3B
Cap. Flow
+$6.99B
Cap. Flow %
1.61%
Top 10 Hldgs %
19.86%
Holding
3,573
New
35
Increased
2,384
Reduced
635
Closed
102

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.16B
2
HSY icon
Hershey
HSY
+$663M
3
LMT icon
Lockheed Martin
LMT
+$622M
4
MO icon
Altria Group
MO
+$525M
5
PFE icon
Pfizer
PFE
+$499M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$2.76B
2
MRK icon
Merck
MRK
+$2.35B
3
ADP icon
Automatic Data Processing
ADP
+$1.57B
4
BX icon
Blackstone
BX
+$1.38B
5
ITW icon
Illinois Tool Works
ITW
+$1.13B

Sector Composition

Rank Sector Weight
1 Technology 22.85%
2 Financials 12.71%
3 Healthcare 11.72%
4 Consumer Discretionary 10.09%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRTG icon
3301
Heritage Insurance Holdings
HRTG
$898M
$108K ﹤0.01%
10,125
BETR icon
3302
Better Home & Finance Holding
BETR
$450M
$106K ﹤0.01%
4,257
FOA icon
3303
Finance of America Companies
FOA
$205M
$104K ﹤0.01%
14,105
PBYI icon
3304
Puma Biotechnology
PBYI
$405M
$103K ﹤0.01%
19,453
OCEA
3305
DELISTED
Ocean Biomedical, Inc. Common Stock
OCEA
$99.6K ﹤0.01%
26,305
ELA icon
3306
Envela
ELA
$568M
$98.8K ﹤0.01%
21,390
LDI icon
3307
loanDepot
LDI
$553M
$95.8K ﹤0.01%
36,986
+2
+0% +$5
GORV
3308
DELISTED
Lazydays
GORV
$95.7K ﹤0.01%
792
SHCO
3309
DELISTED
Soho House & Co
SHCO
$95.3K ﹤0.01%
16,810
GTHX
3310
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$92.9K ﹤0.01%
21,516
SKIL icon
3311
Skillsoft
SKIL
$65.3M
$92.7K ﹤0.01%
10,299
BRDG
3312
DELISTED
Bridge Investment Group
BRDG
$91.6K ﹤0.01%
13,376
CAPR icon
3313
Capricor Therapeutics
CAPR
$221M
$91.5K ﹤0.01%
13,479
TSBX
3314
DELISTED
Turnstone Biologics
TSBX
$90.2K ﹤0.01%
34,443
+19,274
+127% +$55.2K
ZVIA icon
3315
Zevia
ZVIA
$123M
$90.1K ﹤0.01%
77,006
CTV
3316
DELISTED
Innovid Corp.
CTV
$89K ﹤0.01%
35,745
CRDF icon
3317
Cardiff Oncology
CRDF
$68.5M
$87.6K ﹤0.01%
16,399
WHWK
3318
Whitehawk Therapeutics
WHWK
$185M
$86.8K ﹤0.01%
37,075
-8,294
-18% -$16K
VAXX
3319
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
$86.3K ﹤0.01%
120,334
NAGE
3320
Niagen Bioscience
NAGE
$280M
$85.8K ﹤0.01%
24,667
MITT
3321
TPG Mortgage Investment Trust
MITT
$223M
$85.4K ﹤0.01%
13,958
XBIT icon
3322
XBiotech
XBIT
$68M
$85.2K ﹤0.01%
10,477
DVY icon
3323
iShares Select Dividend ETF
DVY
$23.6B
$85.1K ﹤0.01%
76,202
-153,881
-67% -$18M
AMTX icon
3324
Aemetis
AMTX
$106M
$85.1K ﹤0.01%
14,199
ATOS icon
3325
Atossa Therapeutics
ATOS
$20.9M
$82.7K ﹤0.01%
3,064

Similar funds

Charles Schwab's Q1 2024 Portfolio in Review

As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
  • Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
  • Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
  • Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
  • Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
  • Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
  • Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.

Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.